Results 251 to 260 of about 11,210,734 (383)
Liver Surgery in Relation to Diseases of the Colon and Rectum
Ronald W. Raven
openalex +1 more source
An ADDRESS on SOME MISCONCEPTIONS with REGARD to DISEASES of the LIVER: Delivered before the Oldham Medical Society [PDF]
W. H. White
openalex +1 more source
TGF‐β has a complex role in cancer, exhibiting both tumor‐suppressive and tumor‐promoting properties. Using a series of differentiated tumoroids, derived from different stages and mutational background of colorectal cancer patients, we replicate this duality of TGF‐β in vitro. Notably, the atypical but highly aggressive KRASQ22K mutation rendered early‐
Theresia Mair+17 more
wiley +1 more source
A BLOOD COUNT IN A CASE OF HYDATID DISEASE OF THE LIVER. [PDF]
C.J. Nepean Longridge
openalex +1 more source
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau+11 more
wiley +1 more source
ON TWO CASES OF WEILʼS DISEASE COMPLICATED BY THE TEMPORARY APPEARANCE OF SMALL TUMORS IN THE LIVER [PDF]
Max Einhorn
openalex +1 more source
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit+19 more
wiley +1 more source
Diseases of the Bile Passages, Including the Liver, Gall-Bladder and Pancreas [PDF]
MAURICE H. RICHARDSON
openalex +1 more source
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain+3 more
wiley +1 more source